Pshezhetsky A V, Elsliger M A, Vinogradova M V, Potier M
Service de Génétique Médicale, Hôpital Sainte-Justine, Montréal, Québec, Canada.
Biochemistry. 1995 Feb 28;34(8):2431-40. doi: 10.1021/bi00008a005.
Human lysosomal beta-galactosidase is organized as a 680-kDa complex with cathepsin A (also named carboxypeptidase L and protective protein), which is necessary to protect beta-galactosidase from intralysosomal proteolysis. To understand the molecular mechanism of beta-galactosidase protection by cathepsin A, we defined the structural organization of their complex including the beta-galactosidase-binding interface on cathepsin A. Radiation inactivation analysis suggested the existence of a 168-kDa structural subunit of the complex containing both beta-galactosidase and cathepsin A. Chemical cross-linking of the complex confirmed the existence of this subunit and showed that it is composed of one cathepsin A dimer and one beta-galactosidase monomer. The modeling of the cathepsin A dimer tertiary structure based on atomic coordinates of a wheat carboxypeptidase suggested a putative beta-galactosidase-binding cavity formed by the association of two cathepsin A monomers. According to this model two exposed loops of cathepsin A bordering the cavity were chosen as part of a putative beta-galactosidase-binding interface. Synthetic peptides corresponding to these loops were found both to dissociate the complex and to inhibit its in vitro reconstitution from purified cathepsin A and beta-galactosidase. The defined location of the GAL monomer in the complex with 35% of its surface covered by the CathA dimer may explain the stabilizing effect of CathA on GAL in lysosome.
人溶酶体β-半乳糖苷酶与组织蛋白酶A(也称为羧肽酶L和保护蛋白)组装成一个680 kDa的复合物,这对于保护β-半乳糖苷酶免受溶酶体内蛋白水解是必需的。为了了解组织蛋白酶A对β-半乳糖苷酶的保护作用的分子机制,我们确定了它们复合物的结构组织,包括组织蛋白酶A上的β-半乳糖苷酶结合界面。辐射失活分析表明该复合物存在一个168 kDa的结构亚基,其同时包含β-半乳糖苷酶和组织蛋白酶A。该复合物的化学交联证实了这个亚基的存在,并表明它由一个组织蛋白酶A二聚体和一个β-半乳糖苷酶单体组成。基于小麦羧肽酶的原子坐标对组织蛋白酶A二聚体三级结构进行建模,提示由两个组织蛋白酶A单体缔合形成一个假定的β-半乳糖苷酶结合腔。根据这个模型,选择组织蛋白酶A上与该腔相邻的两个暴露环作为假定的β-半乳糖苷酶结合界面的一部分。发现与这些环对应的合成肽既能使复合物解离,又能抑制其从纯化的组织蛋白酶A和β-半乳糖苷酶进行体外重组。在复合物中GAL单体35%的表面被CathA二聚体覆盖,其确定的位置可能解释了CathA在溶酶体中对GAL的稳定作用。